Düsseldorf, July 02, 2020 The vaccines under development to protect against Covid-19 are, like many other drugs, filled in so-called injection or vials made of type 1 borosilicate glass, also known as vials. The large worldwide demand for vials is met by the Gerresheimer Group's plants in Europe, America and Asia, where they are manufactured to high quality standards for customers in the pharmaceutical industry. The Company has already received initial orders for vials for drugs and vaccines against Covid-19.
"Our injection vials, manufactured according to ISO standard, have been successfully used by our customers for decades and have proven themselves in the use with vaccines. Thanks to the continuous development of our portfolio, we are now able to produce a portfolio of injection vials that is geared to the increased needs of our customers. The keyword patient safety is at the heart of all our developments," says Hans-Ulrich Pieper, Senior Director Sales Pharma Parenteral Solutions Europe & MENA, who is responsible for tubular glass products (Tubular Glass Converting).
